Description
Bio-Gene Technology Ltd. engages in the research and development of the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. Its novel platform technology is based on occurring beta-triketones, a type of chemistry that may offer solutions for insect management control in animal health and crop protection as well as in public health applications. The company was founded on November 8, 1995 and is headquartered in Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.05 - 0.13
Trade Value (12mth)
AU$1,560.00
1 week
13.73%
1 month
-3.33%
YTD
-42%
1 year
-47.27%
All time high
0.35
EPS 3 yr Growth
13.600%
EBITDA Margin
%
Operating Cashflow
-$3m
Free Cash Flow Return
-69.00%
ROIC
-65.20%
Interest Coverage
N/A
Quick Ratio
6.20
Shares on Issue (Fully Dilluted)
178m
HALO Sector
Industrials
Next Company Report Date
22-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 July 23 |
Gene Technology Ltd. - Appendix 4E and 2023 Annual Report
×
Gene Technology Ltd. - Appendix 4E and 2023 Annual Report |
31 July 23 |
Gene Technology Ltd. - Appendix 4G
×
Gene Technology Ltd. - Appendix 4G |
31 January 23 |
Gene Technology Ltd. - Appendix 4C - 31 December 2022
×
Gene Technology Ltd. - Appendix 4C - 31 December 2022 |
31 January 22 |
Gene Technology Ltd. - Appendix 4C - 31 December 2021
×
Gene Technology Ltd. - Appendix 4C - 31 December 2021 |
31 August 21 |
Gene Technology Ltd. - Bio-Gene to Present at Australian Mosquito Control Symposium
×
Gene Technology Ltd. - Bio-Gene to Present at Australian Mosquito Control Symposium |
30 September 22 |
Gene Technology Ltd. - Notice Required Under ASX Listing Rule 3.13.1
×
Gene Technology Ltd. - Notice Required Under ASX Listing Rule 3.13.1 |
30 October 23 |
Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report
×
Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report |
30 October 23 |
Gene Technology Ltd. - Appointment of Joint Company Secretary
×
Gene Technology Ltd. - Appointment of Joint Company Secretary |
30 November 22 |
Gene Technology Ltd. - Bio-Gene to Present at Biocides Europe 2022
×
Gene Technology Ltd. - Bio-Gene to Present at Biocides Europe 2022 |
30 November 21 |
Gene Technology Ltd. - Bio-Gene 2021 AGM Presentation
×
Gene Technology Ltd. - Bio-Gene 2021 AGM Presentation |
30 November 21 |
Gene Technology Ltd. - Bio-Gene 2021 AGM - CEO's Presentation
×
Gene Technology Ltd. - Bio-Gene 2021 AGM - CEO's Presentation |
29 October 21 |
Gene Technology Ltd. - 2021 Notice of Annual General Meeting/Proxy Form
×
Gene Technology Ltd. - 2021 Notice of Annual General Meeting/Proxy Form |
29 August 23 |
Gene Technology Ltd. - Initial Director's Interest Notice - T Grogan
×
Gene Technology Ltd. - Initial Director's Interest Notice - T Grogan |
28 October 20 |
Gene Technology Ltd. - 2020 Notice of Annual General Meeting/Proxy Form
×
Gene Technology Ltd. - 2020 Notice of Annual General Meeting/Proxy Form |
28 June 23 |
Gene Technology Ltd. - Allowance of USA Patent
×
Gene Technology Ltd. - Allowance of USA Patent |
28 July 23 |
Gene Technology Ltd. - BGT Appoints New CEO
×
Gene Technology Ltd. - BGT Appoints New CEO |
28 July 23 |
Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report
×
Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report |
28 July 23 |
Gene Technology Ltd. - Chair Appointment/Resignation
×
Gene Technology Ltd. - Chair Appointment/Resignation |
28 July 22 |
Gene Technology Ltd. - Appendix 4C - 30 June 2022
×
Gene Technology Ltd. - Appendix 4C - 30 June 2022 |
27 October 22 |
Gene Technology Ltd. - Appendix 4C - 30 September 2022
×
Gene Technology Ltd. - Appendix 4C - 30 September 2022 |
27 November 23 |
Gene Technology Ltd. - Becoming a substantial holder
×
Gene Technology Ltd. - Becoming a substantial holder |
27 November 19 |
Gene Technology Ltd. - Bio-Gene Presenting at Investor Conferences
×
Gene Technology Ltd. - Bio-Gene Presenting at Investor Conferences |
27 July 23 |
Gene Technology Ltd. - Change of Director's Interest Notice - R Jagger
×
Gene Technology Ltd. - Change of Director's Interest Notice - R Jagger |
27 July 23 |
Gene Technology Ltd. - BGT Executes Agreement with STK
×
Gene Technology Ltd. - BGT Executes Agreement with STK |
27 January 22 |
Gene Technology Ltd. - Results of Meeting - EGM
×
Gene Technology Ltd. - Results of Meeting - EGM |
27 April 23 |
Gene Technology Ltd. - Appendix 4C - 31 March 2023
×
Gene Technology Ltd. - Appendix 4C - 31 March 2023 |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.